CoChat

Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine

Open access

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Chronic constipation is a prevalent functional gastrointestinal disorder accompanied with intestinal dysbiosis. However, causal relationship between dysbiosis and constipation remains poorly understood. Serotonin transporter (SERT) is a transmembrane transport protein which re-uptakes excessive 5-hydroxytryptamine (5-HT) from effective location to terminate its physiological effects and involves in regulating gastrointestinal motility. In this study, fecal microbiota from patients with constipation and healthy controls were transplanted into the antibiotic depletion mice model. The mice which received fecal microbiota from patients with constipation presented a reducing in intestinal peristalsis and abnormal defecation parameters including the frequency of pellet expulsion, fecal weight and fecal water content. After fecal microbiota transplantation, the SERT expression in the colonic tissue was significantly upregulated, and the content of 5-HT was decreased which negatively correlated with the gastrointestinal transit time. Moverover, fecal microbiota from the mice which received fecal microbiota from patients with constipation also upregulated SERT in Caco-2 cells. Besides, this process accompanied with the decreased abundance of Clostridium , Lactobacillus , Desulfovibrio , and Methylobacterium and an increased tend of Bacteroides and Akkermansia , which also involved in the impairment of intestinal barrier after FMT. Taken together, intestinal dysbiosis may upregulate the SERT expression and contribute to the development of chronic constipation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-017-10835-8

Cites

0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The mice receiving fecal microbiota from patients with constipation presented abnormal defecation parameters. Antibiotic mixture (500 mg of ampicillin, 250 mg of vancomycin, 500 mg neomycin and 250 mg of metronidazole) was given by gavage daily for 3 days before FMT. The mice were inoculated with the fecal microbiota for a total of 7 times over the subsequent 2 weeks (A). Parameters of defecation were shown in the blank control, FMT-C group (n = 10), and the FMT-H group (n = 10). In 7th day, frequency of defecation within 2 hours, the changes of fecal weight, dry weight and fecal water within 2 hours in FMT-C group were similar to those in FMT-H group or blank control. While in 15th day, a decrease trend in frequency of defecation within 2 hours, fecal weight, dry weight and fecal water within 2 hours were found in the FMT-C group compared with those in the FMT-H group (B–E). There is no significance between blank control and FMT-H group in the 7th and 15th day. The parameters on the 15th day have significantly decreased in the FMT-C group compared with those in the FMT-H group and blank control. While there was no significant difference between blank control and FMT-C in the 7th day (B–E). FMT, fecal microbiota transplantation; FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls; ND, normal diet; N.S, no significance; *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 1 The mice receiving fecal microbiota from patients with constipation presented abnormal defecation parameters. Antibiotic mixture (500 mg of ampicillin, 250 mg of vancomycin, 500 mg neomycin and 250 mg of metronidazole) was given by gavage daily for 3 days before FMT. The mice were inoculated with the fecal microbiota for a total of 7 times over the subsequent 2 weeks (A). Parameters of defecation were shown in the blank control, FMT-C group (n = 10), and the FMT-H group (n = 10). In 7th day, frequency of defecation within 2 hours, the changes of fecal weight, dry weight and fecal water within 2 hours in FMT-C group were similar to those in FMT-H group or blank control. While in 15th day, a decrease trend in frequency of defecation within 2 hours, fecal weight, dry weight and fecal water within 2 hours were found in the FMT-C group compared with those in the FMT-H group (B–E). There is no significance between blank control and FMT-H group in the 7th and 15th day. The parameters on the 15th day have significantly decreased in the FMT-C group compared with those in the FMT-H group and blank control. While there was no significant difference between blank control and FMT-C in the 7th day (B–E). FMT, fecal microbiota transplantation; FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls; ND, normal diet; N.S, no significance; *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central
Figure 2 Dysbiosis contributed to gastrointestinal motility dysfunction in mice. GITT was used to evaluate the gastrointestinal motility of mice after fecal microbiota transplantation (FMT). GITT in the FMT-C group was decreased compared with that in the FMT-H group (n = 5) (A). Ink propulsion experiment was performed as follow: all of the mice (n = 5) were fasted overnight for 16 h. On the next morning, mice were given ink 0.2 mL/10 g. After a 25 min interval, the mice were killed to collect the segments of stomach to ileocecal junction. Ink propulsion rate (%) = migration distance of ink/whole length of small intestine × 100%. The number of the mice in which the ink reached the ileocecal region was lower in the FMT-C group compared with that in the FMT-H group (40% vs 100%, P < 0.05) (B). Transgelin is an actin stress fibre-associated protein that acts to stabilize actin, which can regulate contractile function of smooth muscle cell. The trangelin expression was decreased in the mice intestinal tissues of FMT-C group, compared with FMT-H group (C). Scale bar: 20 μm. GITT, gastrointestinal transient time; FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls. **P < 0.01.
Figure 2 Dysbiosis contributed to gastrointestinal motility dysfunction in mice. GITT was used to evaluate the gastrointestinal motility of mice after fecal microbiota transplantation (FMT). GITT in the FMT-C group was decreased compared with that in the FMT-H group (n = 5) (A). Ink propulsion experiment was performed as follow: all of the mice (n = 5) were fasted overnight for 16 h. On the next morning, mice were given ink 0.2 mL/10 g. After a 25 min interval, the mice were killed to collect the segments of stomach to ileocecal junction. Ink propulsion rate (%) = migration distance of ink/whole length of small intestine × 100%. The number of the mice in which the ink reached the ileocecal region was lower in the FMT-C group compared with that in the FMT-H group (40% vs 100%, P < 0.05) (B). Transgelin is an actin stress fibre-associated protein that acts to stabilize actin, which can regulate contractile function of smooth muscle cell. The trangelin expression was decreased in the mice intestinal tissues of FMT-C group, compared with FMT-H group (C). Scale bar: 20 μm. GITT, gastrointestinal transient time; FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls. **P < 0.01.CC BY · PubMed Central
Figure 3 Fecal microbiota of constipation patients upregulated SERT levels in the mice intestinal tissues. Realtime-PCR results showed SERT mRNA level was up-regulated in intestinal tissues of the FMT-C group compared with the FMT-H group (A). Intestinal protein levels of SERT in both groups were analyzed by Western blot, using internal control protein β-actin for total protein (B). Proteins were quantified by densitometry using an Imaging processor program (Image J) (C). Similarly, SERT mRNA levels in Caco-2 cells were detected after the treatment with fecal microbiota from the three groups (Blank control, FMT-H, FMT-C) for 3 h, and the concentration of fecal microbiota was 1 to 2000 (D). Protein levels of SERT in Caco-2 cells treated with fecal microbiota from the three groups for 3 h were analyzed by Western blot (E). Quantitative analysis of the protein levels of SERT in Caco-2 cells were processed by densitometry with Image J (F). The uncropped blots with molecular weights are shown in Fig. S2. FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls; SERT, serotonin transporter; N.S, no significance; *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 3 Fecal microbiota of constipation patients upregulated SERT levels in the mice intestinal tissues. Realtime-PCR results showed SERT mRNA level was up-regulated in intestinal tissues of the FMT-C group compared with the FMT-H group (A). Intestinal protein levels of SERT in both groups were analyzed by Western blot, using internal control protein β-actin for total protein (B). Proteins were quantified by densitometry using an Imaging processor program (Image J) (C). Similarly, SERT mRNA levels in Caco-2 cells were detected after the treatment with fecal microbiota from the three groups (Blank control, FMT-H, FMT-C) for 3 h, and the concentration of fecal microbiota was 1 to 2000 (D). Protein levels of SERT in Caco-2 cells treated with fecal microbiota from the three groups for 3 h were analyzed by Western blot (E). Quantitative analysis of the protein levels of SERT in Caco-2 cells were processed by densitometry with Image J (F). The uncropped blots with molecular weights are shown in Fig. S2. FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls; SERT, serotonin transporter; N.S, no significance; *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central
Figure 4 Fecal microbiota of constipation patients decreased 5-HT levels in the mice intestinal tissues. ELISA analysis showed decreased 5-hydroxytryptamine (5-HT) levels in the FMT-C group compared with the FMT-H group (A). The 5-HT level was significantly correlated with GITT (B). 5-HT secreted by intestinal chromaffin cells. Chromaffin granules protein A (CgA) exists in chromaffin cell secretory granules. Paraffin sections of colonic tissues were immunofluorescence stained with primary antibodies against CgA to mark chromaffin cells (Red) and to mark 5-HT (Green) (C). Quantitation of 5-HT+ cell numbers per field of colonic epitheial tissue (D). Quantitation of CgA+ cell number per field of colonic epithelial tissue (E). FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls; 5-HT, 5-hydroxytryptamine; CgA Chromaffin granules protein A; GITT, gastrointestinal transient time. **P < 0.01. n = 10.
Figure 4 Fecal microbiota of constipation patients decreased 5-HT levels in the mice intestinal tissues. ELISA analysis showed decreased 5-hydroxytryptamine (5-HT) levels in the FMT-C group compared with the FMT-H group (A). The 5-HT level was significantly correlated with GITT (B). 5-HT secreted by intestinal chromaffin cells. Chromaffin granules protein A (CgA) exists in chromaffin cell secretory granules. Paraffin sections of colonic tissues were immunofluorescence stained with primary antibodies against CgA to mark chromaffin cells (Red) and to mark 5-HT (Green) (C). Quantitation of 5-HT+ cell numbers per field of colonic epitheial tissue (D). Quantitation of CgA+ cell number per field of colonic epithelial tissue (E). FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls; 5-HT, 5-hydroxytryptamine; CgA Chromaffin granules protein A; GITT, gastrointestinal transient time. **P < 0.01. n = 10.CC BY · PubMed Central
Figure 5 Constipation-induced dysbiosis could be transmitted to the mice. PCA focused on fecal bacterial communities using principal components in two distinct groups. The spatial distance showed the similarity degree of bacterial taxon among samples. FMT-H group: red dots, n = 5; FMT-C group: blue dots; n = 8 (A). The phylum level in the FMT-H and FMT-C groups after the 2 weeks experiment (B). Heatmap results showed the significant difference in abundance between FMT-H and FMT-C groups at important genus and species levels that after the experiment (C,D). Different color showed the relative abundance of the community (from cold to warm color means from low to high abundance). PCA, Principal component analysis; FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls.
Figure 5 Constipation-induced dysbiosis could be transmitted to the mice. PCA focused on fecal bacterial communities using principal components in two distinct groups. The spatial distance showed the similarity degree of bacterial taxon among samples. FMT-H group: red dots, n = 5; FMT-C group: blue dots; n = 8 (A). The phylum level in the FMT-H and FMT-C groups after the 2 weeks experiment (B). Heatmap results showed the significant difference in abundance between FMT-H and FMT-C groups at important genus and species levels that after the experiment (C,D). Different color showed the relative abundance of the community (from cold to warm color means from low to high abundance). PCA, Principal component analysis; FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls.CC BY · PubMed Central
Figure 6 Fecal microbiota of constipation patients disrupted the intestinal barrier function of the mice. PAS staining showed that the average number of PAS positive cells in each crypt of the colon in the FMT-C group was significantly lower than that in the FMT-H group (A). MUC2 immunohistochemistry showed the average number of MUC2-positive cells in the crypts of the mice in the colon in two groups (B). Scale bar: 50 μm. FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls. *P < 0.05, **P < 0.01, n = 10.
Figure 6 Fecal microbiota of constipation patients disrupted the intestinal barrier function of the mice. PAS staining showed that the average number of PAS positive cells in each crypt of the colon in the FMT-C group was significantly lower than that in the FMT-H group (A). MUC2 immunohistochemistry showed the average number of MUC2-positive cells in the crypts of the mice in the colon in two groups (B). Scale bar: 50 μm. FMT-C group, the group that received the fecal microbiota of constipation patients; FMT-H group, the group that received the fecal microbiota of healthy controls. *P < 0.05, **P < 0.01, n = 10.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 67 references

Cited by

See all 253

Metadata

Authors
Cao, H., Liu, X., An, Y., Zhou, G., Liu, Y., Xu, M., Dong, W., Wang, S., Yan, F., Jiang, K., & Wang, B.
Affiliations
  • Tianjin Medical University General Hospital (CN)
  • Tianjin International Joint Academy of Biomedicine (CN)
Corresponding author
  • Jiang, Kui
  • Wang, Bangmao
Venue
Scientific Reports
Published
2017-09-04
Volume
7
Issue
1
Pages
10322-10322
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2751377729
Cited by
253
References
0
Citations by year
2026: 13 · 2025: 27 · 2024: 45 · 2023: 50 · 2022: 37 · 2021: 33 · 2020: 16 · 2019: 20 · 2018: 12
FWCI
13.79
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Natural Science Foundation of China (81470796, 81570478)
  • Ministry of Human Resources and Social Security
  • Technology Foundation for Selected Overseas Scholar, Ministry of Human Resources and Social Security
  • Tianjin Research Program of Application Foundation and Advanced Technology of China (15JCZDJC36600, 81570478)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
Keywords
chronic constipation, gut dysbiosis, serotonin transporter, fecal microbiota transplantation, serotonin, gastrointestinal motility, intestinal peristalsis, gastrointestinal transit time, Akkermansia, Bacteroides, Clostridium, Lactobacillus, Desulfovibrio, Methylobacterium, intestinal barrier, Caco-2 cells
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adolescent, Adult, Animals, Constipation, Disease Models, Animal, Disease Susceptibility, Feces, Female, Humans, Intestinal Mucosa, Male, Middle Aged, RNA, Messenger, Gene Expression, Serotonin Plasma Membrane Transport Proteins, Mice, Young Adult, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. https://app.cochat.ai/papers/10.1038/s41598-017-10835-8
The paper
Cao, H., Liu, X., An, Y., Zhou, G., Liu, Y., Xu, M., Dong, W., Wang, S., Yan, F., Jiang, K., & Wang, B. (2017). Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine. Scientific Reports. https://doi.org/10.1038/s41598-017-10835-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.